Treatment of Netherton Syndrome With Abrocitinib
JAMA Dermatology · 01.07.2023 · 159 (7) · 791
DOI: 10.1001/jamadermatol.2023.0561 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.07.2023. Verfasst von Chun-Chan Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Netherton Syndrome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
This case report describes a 28-year-old woman with Netherton syndrome who had large erythematous migratory patches with serpiginous double-edged scales on her face, neck, trunk, and extremities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, China.
- Guangdong Medical University, Zhanjiang, China.
Zitieren
APA
Zheng, C. C., Chen, X. X., Zou, R. T., Cai, G. Y., & Chen, R. Y. (2023). Treatment of Netherton Syndrome With Abrocitinib. JAMA Dermatology, 159(7), 791. https://doi.org/10.1001/jamadermatol.2023.0561
Vancouver
Zheng CC, Chen XX, Zou RT, Cai GY, Chen RY. Treatment of Netherton Syndrome With Abrocitinib. JAMA Dermatology. 2023;159(7):791. doi:10.1001/jamadermatol.2023.0561
BibTeX
@article{Zheng2023,
author = {Zheng, Chun-Chan and Chen, Xiao-Xuan and Zou, Rui-Tao and Cai, Gui-Yue and Chen, Rong-Yi},
title = {Treatment of Netherton Syndrome With Abrocitinib},
journal = {JAMA Dermatology},
year = {2023},
volume = {159},
number = {7},
pages = {791},
doi = {10.1001/jamadermatol.2023.0561}
}
EUVIMED